Navigation Links
Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
Date:9/14/2009

olecules over the next decade and bring innovative medicines to patients sooner.
  • Organize the company around five global business units: oncology, diabetes, established markets, emerging markets, and Elanco animal health, thereby moving from a predominantly functionally-oriented organization to a business-unit structure.
  • Streamline the organization and align corporate and general and administrative functions to support the business with a focus on improved quality, strong customer service and reduced costs.
  • Reduce the company's cost structure by $1 billion and lower global headcount to 35,000 by the end of 2011, excluding strategic sales additions in high-growth emerging markets and Japan.
  • Explaining the need for such changes, Lechleiter noted that the global pharmaceutical industry is facing unprecedented challenges - slowing innovation, rising costs, patent expiries and increased generic competition, demands from payers to deliver greater value, and health care reform. These forces are reducing industry growth rates and profitability. Lilly faces these and its own challenges, including a series of patent expirations for key products beginning in late 2011.

    "While our financial performance during the past few years has been strong, we will soon enter the most challenging period in our company's history. This calls for strong measures to speed our output of new medicines, better meet the changing needs of our customers and reduce our costs," Lechleiter said.

    Among a number of growth options that could be considered, Lechleiter said management is convinced that Lilly's promising pipeline of early- and mid-stage molecules offers the best possible opportunity for sustainable long-term growth.

    "This is a pivotal moment for our company," said Lechleiter. "The need for breakthrough medicines - to help aging populations, to provide trea
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine news :

    1. Lilly Names New Business Leaders
    2. Chicago Bears Quarterback Jay Cutler, Eli Lilly and Company and the American Diabetes Association Team Up to Fund Diabetes Camp Scholarships Through "Touchdowns for Diabetes"
    3. Lilly Named Best Company for Blacks in Technology
    4. Lilly Reports on Outcome of Phase III Study of Arzoxifene
    5. U.S. District Court Rules Against Lilly Regarding Gemzar Patent
    6. Eli Lilly-Children International Launches Teen Campaign to Reduce TB Cases in India
    7. Lilly Broadens Income Eligibility for Patient Assistance Programs
    8. Lilly Announces Continued Commitment to Transparency with Faculty Registry
    9. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
    10. Lilly Receives Award From National Medical Association
    11. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... auto insurance for senior citizens . , Senior ... does not mean that they cannot find affordable coverage. ... can find the right coverage for their cars at ... like http://lowcostcarinsuranceprice.com/ provides free leads from various ...
    (Date:4/24/2015)... Integrative Therapeutics has introduced two ... and cognition. , A unique combination of herbs ... Wellness Flavonoid Complex apart from other antioxidant supplements. ... to support antioxidation versus the use of single ... tea extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 ...
    (Date:4/24/2015)... With years of experience providing ... proud to be partnered with a veterinary college where ... year. This partnership has brought new payment options for ... After providing an in-house payment plan for many years, ... wanted to increase financing options available to avoid having ...
    (Date:4/24/2015)... (PRWEB) April 24, 2015 IntelliSoft ... provider enrollment and contract management software, featured IntelliCred ... Medical Staff Services Annual Educational Conference (IAMSS) ... Resort in Oak Brook, Illinois. , Notable improvements ... , Contract Linking: A ...
    (Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data event ... suppliers, content providers, associations and government bodies. From industry ... see them converge in Berlin. This year’s start-up competition ... companies currently at the forefront of Europe’s Silicon Valley ... centric products, ParkTAG are one of the first social ...
    Breaking Medicine News(10 mins):Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3
    ... American Heart Association extend their sympathy to the family and friends ... , "It,s a shame when someone his age dies so ... "Although we don,t know all the details of the situation, ... react quickly. Our thoughts and prayers are with the Jackson ...
    ... Wash., June 25 Verathon Inc., maker of ... announced today the appointment of Kendall Stever as ... will include management and oversight of the Company,s ... functions for company headquarters in Washington State, taxation, ...
    ... finds , THURSDAY, June 25 (HealthDay News) -- Consumption of ... associated with it. Worldwide, one in 25 deaths and 5 ... are related to alcohol, according to a new study. , ... of about 1.6 gallons (6.2 liters) of pure ethanol a ...
    ... ... Cases, , ... CO (PRWEB) June 25, 2009 -- Two grocery checkers--a 28-year-old female triathlete and a ... are identical. Which employee will return to work sooner? Is there anything you can ...
    ... In a 6-5 decision in Richmond Medical Center v. ... ban on partial birth infanticide -- a law that mirrors the ... United for Life (AUL) provided litigation support to the ... Virginia,s law. In addition, AUL Senior Counsel Clarke Forsythe assisted ...
    ... there is no cure for HIV/AIDS. However, major advances ... with HIV/AIDS. For example, Dr. Michael Hall has revolutionized ... diseases. He envisions a synergy between the evolution of ... the Hall Longevity Clinic Lifecard , ...
    Cached Medicine News:Health News:American Heart Association Extends Sympathy to Family of Singer Michael Jackson 2Health News:Verathon Inc. Appoints Kendall Stever as Chief Financial Officer 2Health News:Alcohol-Related Ills Increasing Worldwide 2Health News:Alcohol-Related Ills Increasing Worldwide 3Health News:MDGuidelines Offers New Predictive Modeling Feature 2Health News:MDGuidelines Offers New Predictive Modeling Feature 3Health News:MDGuidelines Offers New Predictive Modeling Feature 4Health News:Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute 2Health News:Dr. Hall Revolutionizes National HIV Testing Day 2
    (Date:4/24/2015)... 2015  Novartis Pharmaceuticals Corporation (NPC) has been named the ... row on the annual DiversityInc Top 50 Companies for Diversity ... Companies for Diversity on April 23 at an awards ceremony ... ranked second on the DiversityInc Top 10 Companies for Recruitment ... Resource Groups list. David Epstein , ...
    (Date:4/24/2015)... , April 24, 2015 Hospira, Inc. ... the development of biosimilar therapies, spoke about the importance ... the European Generics Association (EGA) annual European Biosimilars Group ... The company also announced the publication of a pivotal ... achieving the full promise of biosimilars." ...
    (Date:4/23/2015)... (NYSE: RMD ) today announced results for its ... was $422.5 million, a 6 percent increase compared to ... increase on a constant currency basis).  Net income was ... the quarter ended March 31, 2014.  Diluted earnings per ... 2 percent compared to the quarter ended March 31, ...
    Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13
    ... Dec. 20, 2010 Ambit Biosciences (Ambit), ... trials for two products AC430, a selective Janus Kinase ... The Phase I trial for AC430 is a ... trial in healthy volunteers.  AC430 will be administered orally ...
    ... Center for Business Intelligence (CBI) has been recognized as a ... was awarded recently to Kathleen Y. Coffey, CBI President, by ... Boston Park Plaza Hotel.   The Top ... $47.5B in annual revenue and $202,664 employees. Over 500 women ...
    Cached Medicine Technology:Ambit Biosciences Initiates Two Phase I Clinical Trials 2The Center for Business Intelligence (CBI) Receives Top 100 Women-Led Businesses Award 2
    ... Varicella-Zoster Virus (VZV) IgG Enzyme-Linked Immunosorbent ... and quantitative determination of IgG antibody to ... specimens may be used for the determination ... convalescent, may be used to demonstrate seroconversion ...
    ... Inc. Mumps IgG ELISA test system is ... IgG antibody in human serum. When performed ... this test, together with other clinical information, ... status, and/or aid in the diagnosis of ...
    ... Mumps IgM Enzyme-Linked Immunosorbent Assay ... qualitative detection of IgM antibody ... for the determination of immunological ... this kit have not been ...
    The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
    Medicine Products: